Ausgabe 1/2013
Inhalt (25 Artikel)
Malignant ascites: pathophysiology and treatment
Emanuel Cavazzoni, Walter Bugiantella, Luigina Graziosi, Maria Silvia Franceschini, Annibale Donini
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer
Takahiro Tsushima, Shuichi Hironaka, Narikazu Boku, Nozomu Machida, Kentaro Yamazaki, Hirofumi Yasui, Akira Fukutomi, Akiko Todaka, Hiroya Taniguchi, Yusuke Onozawa, Keisei Taku
Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer
Shiro Tanaka, Kazuhiro Yanagihara, Satoshi Tamaru, Satoshi Teramukai, Toshiyuki Kitano, Masanori Fukushima
The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer
Xiao Feng Duan, Na Na Dong, Ti Zhang, Qiang Li
Caffeine-potentiated chemotherapy for clear cell sarcoma: a report of five cases
Michiaki Karita, Hiroyuki Tsuchiya, Norio Yamamoto, Toshiharu Shirai, Katsuhiro Hayashi, Hideji Nishida
Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients
Tatsuo Kanda, Toshirou Nishida, Norihito Wada, Osamu Kobayashi, Masakazu Yamamoto, Akira Sawaki, Narikazu Boku, Masato Koseki, Toshihiko Doi, Yasushi Toh, Yoshihiro Kakeji, Toshiro Sugiyama, Yoshito Komatsu, Shojiro Kikuchi, Kyoji Ogoshi, Hitoshi Katai, Kazuhito Miyachi, Seiichi Hirota, Atsushi Ohtsu
Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images
Haruyuki Takaki, Koichiro Yamakado, Atsuhiro Nakatsuka, Tomomi Yamada, Junji Uraki, Masataka Kashima, Takashi Yamanaka, Katsuya Shiraki, Yoshiyuki Takei, Kan Takeda
Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy
Tomoya Nagao, Takayuki Kinoshita, Nobuko Tamura, Takashi Hojo, Madoka Morota, Yoshikazu Kagami
Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study
Tomoyuki Shimabukuro, Shigeru Sakano, Kenji Matsuda, Yoriaki Kamiryo, Norio Yamamoto, Yoshitaka Kaneda, Takahito Nasu, Yoshikazu Baba, Akinobu Suga, Mitsutaka Yamamoto, Akihiko Aoki, Kimio Takai, Satoru Yoshihiro, Motohiko Konishi, Katsuhiko Imoto, Hideyasu Matsuyama
Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinoma
Shiro Hinotsu, Koji Kawai, Seiichiro Ozono, Tomoyasu Tsushima, Noriaki Tokuda, Koichiro Nomata, Seiji Naito, Hideyuki Akaza
Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer
Koji Ichihara, Hiroshi Kitamura, Naoya Masumori, Fumimasa Fukuta, Taiji Tsukamoto
Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinoma
Hideaki Miyake, Yuji Kusuda, Ken-ichi Harada, Iori Sakai, Masato Fujisawa
Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial
Toshihiko Doi, Tetsuya Hamaguchi, Kuniaki Shirao, Kensho Chin, Kiyohiko Hatake, Kazuo Noguchi, Tetsuya Otsuki, Anish Mehta, Atsushi Ohtsu
Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials
Ryoichi Yano, Aya Konno, Kyohei Watanabe, Hitoshi Tsukamoto, Yuichiro Kayano, Hiroaki Ohnaka, Nobuyuki Goto, Toshiaki Nakamura, Mikio Masada
Cervical stromal involvement can predict survival in advanced endometrial carcinoma: a review of 67 patients
Salih Taşkın, Fırat Ortaç, Korhan Kahraman, Göksu Göç, Derya Öztuna, Mete Güngör
Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?
Kensuke Bekku, Takashi Saika, Yasuyuki Kobayashi, Ryo Kioshimoto, Taiki Kanbara, Yasutomo Nasu, Hiromi Kumon
Enhanced antitumor effect of lower-dose and longer-term CPT-11 treatment in combination with low-dose celecoxib against neuroblastoma xenografts
Setsuko Kaneko, Michio Kaneko, Takashi Fukushima
Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study
Kimio Ushijima, Toshiharu Kamura, Kazuo Tamura, Kazuo Kuzuya, Toru Sugiyama, Kiichiro Noda, Kazunori Ochiai
Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer
Yuko Tanabe, Kenji Hashimoto, Chikako Shimizu, Akihiro Hirakawa, Kenichi Harano, Mayu Yunokawa, Kan Yonemori, Noriyuki Katsumata, Kenji Tamura, Masashi Ando, Takayuki Kinoshita, Yasuhiro Fujiwara
Factors associated with the survival of patients with primary small cell carcinoma of the kidney
Shen-Yang Lee, Hsiang-Hao Hsu, Hui-Yi Lin, Yung-Chang Chen, Yon-Cheong Wong, Li-Jen Wang, Kwai-Fong Ng, Cheng-Keng Chuang, Cheng-Chieh Hung, Chih-Wei Yang
Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients
Kiyoshi Yoshino, Takayuki Enomoto, Masami Fujita, Yutaka Ueda, Toshihiro Kimura, Eiji Kobayashi, Tateki Tsutsui, Tadashi Kimura
Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma
Takahiro Kiyosue, Shintaro Kawano, Ryota Matsubara, Yuichi Goto, Mitsuhiro Hirano, Teppei Jinno, Takeshi Toyoshima, Ryoji Kitamura, Kazunari Oobu, Seiji Nakamura
Prognostic factors for patients with solitary bone metastasis
Manabu Hoshi, Jun Takada, Makoto Ieguchi, Shinji Takahashi, Hiroaki Nakamura
Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas
Koichi Ogura, Takahiro Goto, Jungo Imanishi, Yusuke Shinoda, Tomotake Okuma, Yusuke Tsuda, Hiroshi Kobayashi, Toru Akiyama, Makoto Hirata, Aiichiro Yamamoto, Hirotaka Kawano
Carboplatin–gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer
Yasuhiro Hashimoto, Kengo Imanishi, Noriko Tokui, Teppei Okamoto, Akiko Okamoto, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Chikara Ohyama